Immunotherapeutic effect of photothermal-mediated exosomes secreted from breast cancer cells

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Recht A, Come SE, Henderson IC et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N. Engl. J. Med. 334(21), 1356–1361 (1996).
  Medline CASGoogle Scholar
• 2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97(5), 418–428 (1994).
  Medline CASGoogle Scholar
• 3. Wang X, Yang L, Chen Z, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 58(2), 97–110 (2008).
  MedlineGoogle Scholar
• 4. Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem. Soc. Rev. 48(7), 2053–2108 (2019). • Comprehensive review on different agents that can also be used in photothermal therapy and photoacoustic imaging that are promising next-generation noninvasive cancer theranostic techniques.
  Medline CASGoogle Scholar
• 5. Li C, Xu Y, Tu L et al. Rationally designed Ru (II)-metallacycle chemo-phototheranostic that emits beyond 1000 nm. Chem. Sci. 13(22), 6541–6549 (2022).
  MedlineGoogle Scholar
• 6. Chen Y-W, Su Y-L, Hu S-H, Chen S-Y. Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment. Adv. Drug Deliv. Rev. 105, 190–204 (2016).
  Medline CASGoogle Scholar
• 7. Zhao L, Zhang X, Wang X, Guan X, Zhang W, Ma J. Recent advances in selective photothermal therapy of tumor. J. Nanobiotechnol. 19(1), 1–15 (2021).
  Medline CASGoogle Scholar
• 8. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 23(3), 217–228 (2008).
  MedlineGoogle Scholar
• 9. Kuo WS, Chang CN, Chang YT et al. Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angewandte Chemie 122(15), 2771–2775 (2010).
  Google Scholar
• 10. Kim HS, Lee DY. Near-infrared-responsive cancer photothermal and photodynamic therapy using gold nanoparticles. Polymers 10(9), 961 (2018).
  MedlineGoogle Scholar
• 11. Breitenborn H, Dong J, Piccoli R et al. Quantifying the photothermal conversion efficiency of plasmonic nanoparticles by means of terahertz radiation. APL Photon. 4(12), 1261061–1261069 (2019).
  Google Scholar
• 12. Li X, Yong T, Wei Z et al. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat. Comm. 13(1), 1–19 (2022). •• A intelligent study in order to boost photothermal therapy-induced antitumor immunity enough to control the growth of solid tumor and overcome the tumor immunosuppressive microenvironment.
  MedlineGoogle Scholar
• 13. Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nat. Med. 21(10), 1128–1138 (2015).
  Medline CASGoogle Scholar
• 14. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12(12), 860–875 (2012).
  Medline CASGoogle Scholar
• 15. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Ann. Rev. Immunol. 20(1), 395–425 (2002).
  Medline CASGoogle Scholar
• 16. Multhoff G, Pockley AG, Streffer C, Gaipl US. Dual role of heat shock proteins (HSPs) in anti-tumor immunity. Curr. Mol. Med. 12(9), 1174–1182 (2012).
  Medline CASGoogle Scholar
• 17. Tang D, Kang R, Cheh C-W et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29(38), 5299–5310 (2010).
  Medline CASGoogle Scholar
• 18. Goetz M, Toft D, Ames M, Erlichman C. The HSP90 chaperone complex as a novel target for cancer therapy. Ann. Oncol. 14(8), 1169–1176 (2003).
  Medline CASGoogle Scholar
• 19. Paudel YN, Angelopoulou E, Piperi C, Balasubramaniam VR, Othman I, Shaikh MF. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: updates on receptor signalling. Eur. J. Pharmacol. 858, DOI: 10.1016/j.ejphar.2019.172487 (2019).
  MedlineGoogle Scholar
• 20. Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20(2), 95–112 (2020).
  Medline CASGoogle Scholar
• 21. Kielbik M, Szulc-Kielbik I, Klink M. Calreticulin – multifunctional chaperone in immunogenic cell death: potential significance as a prognostic biomarker in ovarian cancer patients. Cells 10(1), 130 (2021).
  Medline CASGoogle Scholar
• 22. Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Ann. Rev. Immunol. 31, 51–72 (2013).
  MedlineGoogle Scholar
• 23. Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat. Immunol. 23(4), 487–500 (2022). • The goal of this study was to comprehend how the immune response is affected by signals released by dying mammalian cells. The importance of immunogenic cell death in adaptive immune responses to infected or cancerous cells is emphasized, and this has significant ramifications for noninfectious, nonmalignant illnesses linked to autoreactivity.
  Medline CASGoogle Scholar
• 24. Podolska MJ, Shan X, Janko C et al. Graphene-induced hyperthermia (GIHT) combined with radiotherapy fosters immunogenic cell death. Front. Oncol. 11, 1–12 (2021).
  Google Scholar
• 25. Vulpis E, Cecere F, Molfetta R et al. Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis. Oncoimmunology 6(3), e1279372 (2017).
  MedlineGoogle Scholar
• 26. Jella K, Nasti T, Li Z et al. Post-irradiated tumor-derived exosomes lead to melanoma tumor growth delay, potentially mediated by death associated molecular pattern (damps) proteins. Int. J. Radiat. Oncol. Biol. Phys. 102(3), S155 (2018).
  MedlineGoogle Scholar
• 27. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14(3), 195–208 (2014). • Extracellular vesicles are the subject of this study, which focuses on their function in intercellular communication, their contribution to immunological regulation and their potential therapeutic benefits, notably in the treatment of inflammatory illnesses, autoimmune conditions and cancer.
  Medline CASGoogle Scholar
• 28. Theodoraki M-N, Laban S, Jackson E et al. Changes in circulating exosome molecular profiles following surgery/(chemo) radiotherapy: early detection of response in head and neck cancer patients. Br. J. Cancer 125(12), 1677–1686 (2021). •• As plasma-derived exosomes carry immunomodulatory molecules that correlate with clinical parameters, this study explores the use of these exosomes in head and neck cancer patients as a potential biomarker for early detection of treatment failure and disease recurrence.
  Medline CASGoogle Scholar
• 29. Najaflou M, Shahgolzari M, Khosroushahi AY, Fiering S. Tumor-derived extracellular vesicles in cancer immunoediting and their potential as oncoimmunotherapeutics. Cancers 15(1), 82 (2022).
  MedlineGoogle Scholar
• 30. Sweeney EE, Cano-Mejia J, Fernandes R. Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma. Small 14(20), e1800678 (2018).
  MedlineGoogle Scholar
• 31. Wang X, Li J, Kawazoe N, Chen G. Photothermal ablation of cancer cells by albumin-modified gold nanorods and activation of dendritic cells. Materials 12(1), 31 (2018).
  MedlineGoogle Scholar
• 32. Wang C, Xu L, Liang C, Xiang J, Peng R, Liu Z. Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv. Mater. 26(48), 8154–8162 (2014).
  Medline CASGoogle Scholar
• 33. Huang L, Li Y, Du Y et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat. Comm. 10(1), 1–15 (2019). •• This study suggests a method known as ‘local symbiotic mild photothermal-assisted immunotherapy’ that uses photothermal therapy to make ‘cold’ tumors susceptible to immune checkpoint inhibition. This method involves loading a photothermal agent and programmed death-ligand 1 antibody into a lipid-gel depot, which increases the amount of infiltrated lymphocytes into the tumors and improves T-cell activity against tumors.
  MedlineGoogle Scholar
• 34. Huang Z, Wang Y, Yao D, Wu J, Hu Y, Yuan A. Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress. Nat. Comm. 12(1), 1–18 (2021).
  Medline CASGoogle Scholar
• 35. Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17(11), 657–674 (2020).
  MedlineGoogle Scholar
• 36. Nam J, Son S, Ochyl LJ, Kuai R, Schwendeman A, Moon JJ. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nat. Comm. 9(1), 1–13 (2018).
  MedlineGoogle Scholar
• 37. Li W, Yang J, Luo L et al. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat. Comm. 10(1), 1–16 (2019).
  MedlineGoogle Scholar
• 38. Ali MR, Snyder B, El-Sayed MA. Synthesis and optical properties of small Au nanorods using a seedless growth technique. Langmuir 28(25), 9807–9815 (2012).
  Medline CASGoogle Scholar
• 39. Tebbe M, Kuttner C, Männel M, Fery A, Chanana M. Colloidally stable and surfactant-free protein-coated gold nanorods in biological media. ACS Appl. Mater. Interfaces 7(10), 5984–5991 (2015).
  Medline CASGoogle Scholar
• 40. Richardson HH, Carlson MT, Tandler PJ, Hernandez P, Govorov AO. Experimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutions. Nano Letters 9(3), 1139–1146 (2009).
  Medline CASGoogle Scholar
• 41. Ge J, Jia Q, Liu W et al. Red-emissive carbon dots for fluorescent, photoacoustic, and thermal theranostics in living mice. Adv. Mater. 27(28), 4169–4177 (2015).
  Medline CASGoogle Scholar
• 42. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protocol. Cell Biol. 30(1), 3.22.21–3.22.29 (2006).
  Google Scholar
• 43. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76(9), 4350–4354 (1979).
  Medline CASGoogle Scholar
• 44. Shahgolzari M, Pazhouhandeh M, Milani M, Fiering S, Khosroushahi AY. Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model. Nanomedicine 16(2), 97–107 (2021).
  CASGoogle Scholar
• 45. Berne BJ, Pecora R. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. Courier Corporation, Washington, DC, USA (2000).
  Google Scholar
• 46. Arenas-Guerrero P, Delgado ÁV, Donovan KJ et al. Determination of the size distribution of non-spherical nanoparticles by electric birefringence-based methods. Sci. Rep. 8(1), 9502 (2018).
  MedlineGoogle Scholar
• 47. Reimer L. Transmission Electron Microscopy: Physics of Image Formation and Microanalysis. Springer, New York, NY, USA, 36 (2013).
  Google Scholar
• 48. Clogston JD, Patri AK. Zeta potential measurement. Methods Mol. Biol. 697, 63–70 (2011).
  Medline CASGoogle Scholar
• 49. James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol. Rev. 92(2), 897–965 (2012).
  Medline CASGoogle Scholar
• 50. Zhang JZ, Noguez C. Plasmonic optical properties and applications of metal nanostructures. Plasmonics 3(4), 127–150 (2008).
  CASGoogle Scholar
• 51. Qin Z, Wang Y, Randrianalisoa J et al. Quantitative comparison of photothermal heat generation between gold nanospheres and nanorods. Sci. Rep. 6(1), 29836 (2016).
  Medline CASGoogle Scholar
• 52. Gamrekelashvili J, Ormandy LA, Heimesaat MM et al. Primary sterile necrotic cells fail to cross-prime CD8⁺ T cells. Oncoimmunology 1(7), 1017–1026 (2012).
  MedlineGoogle Scholar
• 53. Li Y, He L, Dong H et al. Fever-inspired immunotherapy based on photothermal CpG nanotherapeutics: the critical role of mild heat in regulating tumor microenvironment. Adv. Sci. 5(6), doi: 10.1002/advs.201700805 (2018). •• A photothermal CpG nanotherapeutics approach is introduced that employs low-intensity heat to create an immunofavorable tumor microenvironment, resulting in improved antitumor immune effects, activated immune responses and apoptotic cell death.
  Google Scholar
• 54. Taylor ML, Wilson RE Jr, Amrhein KD, Huang X. Gold nanorod-assisted photothermal therapy and improvement strategies. Bioengineering 9(5), 200 (2022).
  Medline CASGoogle Scholar
• 55. Ali MR, Rahman MA, Wu Y et al. Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice. Proc. Natl Acad. Sci. USA 114(15), E3110–E3118 (2017).
  Medline CASGoogle Scholar
• 56. Kannadorai RK, Liu Q. Optimization in interstitial plasmonic photothermal therapy for treatment planning. Med. Phys. 40(10), 103301 (2013).
  MedlineGoogle Scholar
• 57. Dickerson EB, Dreaden EC, Huang X et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 269(1), 57–66 (2008).
  Medline CASGoogle Scholar
• 58. Kang X, Guo X, Niu X et al. Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer. Sci. Rep. 7(1), 42069 (2017).
  Medline CASGoogle Scholar
• 59. Schachter D. The Source of Toxicity in CTAB and CTAB-Stabilized Gold Nanorods. Rutgers, The State University of New Jersey, NJ, USA (2013).
  Google Scholar
• 60. Leroueil PR, Hong S, Mecke A, Baker JR Jr, Orr BG, Banaszak Holl MM. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc. Chem. Res. 40(5), 335–342 (2007).
  Medline CASGoogle Scholar
• 61. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146(1), 3 (1995).
  Medline CASGoogle Scholar
• 62. Wang L, Liu Y, Li W et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett. 11(2), 772–780 (2011).
  Medline CASGoogle Scholar
• 63. Morlé A, Garrido C, Micheau O. Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion. Cell Death Dis. 6(2), e1633–e1633 (2015).
  Medline CASGoogle Scholar
• 64. Hildebrandt B, Wust P, Ahlers O et al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol./Hematol. 43(1), 33–56 (2002).
  MedlineGoogle Scholar
• 65. De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front. Immunol. 6, 203 (2015).
  MedlineGoogle Scholar
• 66. Cho J-A, Lee Y-S, Kim S-H, Ko J-K, Kim C-W. MHC independent anti-tumor immune responses induced by HSP70-enriched exosomes generate tumor regression in murine models. Cancer Lett. 275(2), 256–265 (2009).
  Medline CASGoogle Scholar
• 67. Komarova EY, Suezov RV, Nikotina AD et al. HSP70-containing extracellular vesicles are capable of activating of adaptive immunity in models of mouse melanoma and colon carcinoma. Sci. Rep. 11(1), 1–16 (2021).
  MedlineGoogle Scholar
• 68. Khandelwal A, Kent CN, Balch M et al. Structure-guided design of an HSP90β N-terminal isoform-selective inhibitor. Nat. Comm. 9(1), 1–7 (2018).
  Medline CASGoogle Scholar
• 69. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425), 248–251 (1999).
  Medline CASGoogle Scholar
• 70. Tugues S, Burkhard S, Ohs IA et al. New insights into IL-12-mediated tumor suppression. Cell Death Different 22(2), 237–246 (2015).
  Medline CASGoogle Scholar
• 71. Tulotta C, Lefley DV, Moore CK et al. IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. NPJ Breast Cancer 7(1), 1–15 (2021).
  MedlineGoogle Scholar
• 72. Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J. Immunol. 186(4), 2219–2228 (2011).
  Medline CASGoogle Scholar
• 73. Guo D, Chen Y, Wang S et al. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6. Immunology 154(1), 132–143 (2018).
  Medline CASGoogle Scholar
• 74. Loi S, Drubay D, Adams S et al. Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers. J. Clin. Oncol. 37(7), 559 (2019).
  MedlineGoogle Scholar
• 75. Liu Y-T, Sun Z-J. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics 11(11), 5365 (2021). • Discusses various strategies, including nanomedicines, to convert cold tumors into hot tumors with increased T-cell infiltration and improved immune checkpoint inhibitor efficacy, suggesting the potential for multiple T cell-based combination therapies.
  Medline CASGoogle Scholar